Agenda – 2021

23rd Annual MAD-ID Meeting
May 19-22, 2021

The agenda outlined below was that intended for the now cancelled 23rd Annual Meeting. The majority of topics and speakers will be included at the 2021 Meeting. This agenda will be finalized and updated here in the fall of 2020.

NOTE:  “AASP” denotes an Advanced Antimicrobial Stewardship Program session (entire program constitutes 18 hours CPE [1.8 CEU] and 18 hours CME (AMA PRA Category 1 Credit(s)™)

Wednesday, May 19, 2021
12:00 pm - 7:00 pmRegistration
2:00 pm - 3:30 pmTrainee Pre-Meeting Program
Give Me the Good News First: Transitioning into Infectious Diseases Practice; Erin McCreary, PharmD
4:00 pm - 6:00 pmClassrooms #1-4 (attend two of the four offered)
Effective use of EMR Programming to Implement Antibiotic Guidelines/pathways (AASP); David Ha, PharmD; Stewardship Classroom #1 (repeated)
Activity Type: Application
ACPE Program: TBA (1.0 Contact Hour)
Learning Objectives:
1. Discuss best practices of electronic medical record design to improve compliance with clinical guidelines
2. List tools within electronic medical records that can be used in implementing or monitoring antimicrobial stewardship strategies
3. Given a clinical problem, design a potential solution utilizing electronic medical record technologies
Dose Optimization of Beta-lactams (AASP); Charles Peloquin, PharmD; Stewardship Classroom #2
Activity Type: Application
ACPE Program: TBA (1.0 Contact Hour)
Learning Objectives:
1. Describe the key pharmacokinetic/pharmacodynamic parameters that optimize beta-lactam antibiotics
2. Compare beta-lactams that are good candidates for dose optimization strategies
3. Demonstrate examples of successful beta-lactam optimization programs that have improved patient outcomes
Supporting ID/ASP Professionals: Preventing Burnout in an Era of Doing More with Less (AASP); Erin McCreary, PharmD; Stewardship Classroom #3 (repeated)
Activity Type: Application
ACPE Program: TBA (1.0 Contact Hour)
Learning Objectives:
1. Describe the prevalence and consequences of burnout in healthcare professions in the context of infectious diseases workforce
2. Compare the typical causes of burnout in individuals and analyze the systemic contributing factors
3. Demonstrate prevention strategies for mitigating burnout
Developing and Using your Antibiogram; John Bosso, PharmD; Stewardship Classroom #4 (repeated)
Activity Type: Application
ACPE Program: TBA (1.0 Contact Hour)
Learning Objectives:
1. State/list the basic requirements for assembly and dissemination of an antibiogram as suggested by CLSI
2. Summarize the susceptibility data that should and should not be included in an antibiogram
3. Assemble a combination antibiogram and demonstrate its application/use in clinical decision making to clinicians.
6:30 pm - 8:00 pmOpening Reception
Thursday, May 20, 2021
6:30 am – 6:30 pmRegistration/Hospitality Desk
7:00 am - 8:00 amContinental Breakfast In Exhibit Area
8:00 am – 10:00 amClassrooms #5-8 (attend two of the four offered)
Antimicrobial Stewardship in Challenging Environments (AASP); Eddie Stenehjem, MD; Stewardship Classroom #5 (repeated)
Activity Type: Application
ACPE Program: TBA (1.0 Contact Hour)
Learning Objectives:
1. Outline challenges to implementing antimicrobial stewardship in various healthcare settings (e.g. rural, small hospital, telehealth)
2. Identify creative approaches to improving access to antimicrobial stewardship expertise
3. Give an example of how a healthcare network can be used to facilitate antibiotic stewardship in a challenging setting
How to Interpret and Apply Data from in vitro Studies to Patient Care (AASP); Katie Barber, PharmD; Stewardship Classroom #6. (repeated)
Activity Type: Application
ACPE Program: TBA (1.0 Contact Hour)
Learning Objectives:
1. Describe the types of in vitro susceptibility and pharmacodynamic data that are available in the literature
2. List the pros and cons for using this data for clinical translation
3. Given a clinical situation, explain how this data could be useful for specific antibiotic therapy
How to Win Friends and Influence Outpatient Antibiotic Use (AASP); Lisa Dumkow, PharmD; Stewardship Classroom #7 (repeated)
Activity Type: Application
ACPE Program: TBA (1.0 Contact Hour)
Learning Objectives:
1. State two or more rationales for expansion of an antimicrobial stewardship program into the outpatient arena
2. List two or more parties delivering care in the outpatient environment who would be natural partners for stewardship efforts
3. Propose and defend at least two stewardship initiatives that are likely to affect appropriateness of antimicrobial use and/or safety in the outpatient environment
Tales from the Trenches: Difficult Stewardship Challenges from our Community; Susan Davis, PharmD (facilitator); Stewardship Classroom #8 (repeated)
Activity Type: Application
ACPE Program: TBA (1.0 Contact Hour)
Learning Objectives:
1. Compare strategies for implementing new antibiotics in the management of patients with MDR Gram-negative infections
2. Outline a systematic approach for recommending optimal therapy in patients with C. difficile infection
3. Explain how provider-level antibiotic use data can be used to improve de-escalation of broad spectrum antibiotics
10:00 am – 10:30 amBreak in Exhibit Area
10:30 am – 10:45 amWelcome and Opening Remarks
10:45 am – 11:45 amKeynote: Evolution of PK/PD: Impact on Contemporary Therapeutics (AASP), George Drusano, MD
ACPE Program: TBA (1.0 Contact Hour)
Activity Type: Knowledge
Learning Objectives:
1. Describe the origins of the application of PK/PD principles
2. List the most important PK/PD parameters for adjusting and optimizing antibiotic therapy
3. List some of the current and future challenges for the application of PK/PD methods to patient care
11:45 am - 1:30 pmLunch Break
1:30 pm – 3:00 pmCombination Therapy for Serious Infections (AASP)
ACPE Program: TBA (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Combination Therapy for Serious Infections: Staphylococcus aureus; George Sakoulas, MD
Learning Objectives:
1. Describe the clinical challenges of treating serious S. aureus infections
2. Explain the rationale for the use of combination therapy and the controversies surrounding treatment
3. Recommend potential patient scenarios where combination therapy would be most beneficial
Topic 2: Combination Therapy for Serious Infections: Gram-negative Infectious; Ryan Shields, PharmD, MS
Learning Objectives:
1. Discuss the challenges associated with the treatment of gram-negative pathogens
2. Describe the in vitro and animal data that support combination therapy for gram-negative pathogens
3. Discuss the controversies and potential studies needed to support the use of combination therapy
3:00 pm - 3:30 pmBreak in Exhibit Area
3:30 pm - 5:00 pmCOVID-19 (AASP)
ACPE Program: TBA (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Public Health and Clinical Challenges. Roger Bedimo, MD
Learning Objectives:
1. Explain the evolving incidence and epidemiology of COVID-19
2. Compare the manifestations of mild, moderate and severe COVID-19 disease
3. Analyze and describe the current data regarding post-COVID sequelae
Topic 2: Treatment Challenges, Access and Impact of AMS since COVID-19 Outbreak; Julie Ann Justo, PharmD, MS
Learning Objectives:
1. Recommend guidelines and protocols in improve treatment for COVID-19
2. Describe two or more ways that AMS has changed since the COVID-19 pandemic began
3. Describe how the access and pharmacy restrictions to COVID-related treatment affects patients
5:00 pm – 6:30 pmScientific Poster Session / Wine Reception in Exhibit Area
Friday, May 21, 2021
6:30 am - 6:00 pmHospitality Desk Open
7:00 am – 8:00 amContinental Breakfast In Exhibit Area
8:00 am – 9:30 amA Public Health Crisis: Vaccines (AASP)
ACPE Program TBA (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Advances in Vaccines; Jeffrey Goad, PharmD, MPH
Learning Objectives:
1. List newer vaccines and explain the importance/clinical relevance of their introduction
2. List recently updated/improved vaccine products and explain the importance/clinical relevance of those changes
3. List recent changes in ACIP guidelines and adhere to those changes in clinical practice
Topic 2: Vaccine Mythbusters; Marc Hutchinson, PhD
Learning Objectives:
1. List two or more common myths regarding standard immunizations (as recommended by ACIP)
2. Describe the sources of information antivaxers cite to justify their beliefs
3. Propose two or more arguments that might be effective in convincing doubtful patients to accept standard vaccinations
9:30 am - 10:00 amBreak in Exhibit Area
10:00 am – 11:30 amAntimicrobial Stewardship in Special Populations (AASP)
ACPE Program: 0485-0000-20-013-L01-P (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Pediatrics; Tracy Zembles, PharmD
Learning Objectives:
1. Explain how differences in pediatric infectious disease epidemiology or management that call for difference in stewardship initiatives
2. Design a stewardship initiative for implementation that has proven effective in the pediatric inpatient environment
3. Describe two or more stewardship initiatives that have proven effective in the pediatric outpatient environment
Topic 2: Adults with Cystic Fibrosis; Wendy Bullington, PharmD
Learning Objectives:
1. List one or more opportunities for impactful stewardship initiatives in the cystic fibrosis population
2. Describe the elements of successful stewardship interventions that have a proven effect in adult cystic fibrosis patients
3. Justify use of healthcare personnel for stewardship activities in inpatient and/or outpatient cystic fibrosis care programs
11:45 am – 1:30 pmLunch Break
1:30 pm – 3:00 pmA New Era in HIV Management
ACPE Program: TBA (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: New Therapies, New Problems; Roger Bedimo, MD
Learning Objectives:
1. Describe recent trends in the epidemiology of HIV
2. Explain the strengths and limitations of new treatments for HIV to patients and other healthcare providers
3. Identify factors that can complicate choice of antiretroviral therapy for patients with HIV
Topic 2: Real Life Challenges in HIV Therapy; Melissa Badowski, PharmD, MPH
Learning Objectives:
1. Evaluate the impact of generic antiretrovirals on management of HIV in the United States
2. Outline approaches for improving access to care for patients with HIV or at high risk
3. Given a patient case, identify safety considerations important in the selection and monitoring of antiretroviral therapy
3:00 pm - 3:30 pmBreak in Exhibit Area
3:30 pm – 5:00 pmImplementing the 2020 Vancomycin Dosing and Monitoring Guidelines: Finding a Path Forward (AASP)
ACPE Program: TBA (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Demystifying Two-sample and Bayesian Estimated AUC: Simple but no Simpler; Amit Pai, PharmD
Learning Objectives:
1.Review the translational relationship between different measurements of exposure
2. Compare AUC estimates for a given clinical scenario based on 1-sample and 2-sample measurements
3. Contrast the advantages and disadvantages of Bayesian and 2-sample methods for vancomycin dosing and monitoring
Topic 2:Implementing the 2020 vancomycin dosing and monitoring guidelines: Finding a path forward; Emily Heil, PharmD
Learning Objectives:
1. Provide an overview of the key components for implementing the 2020 vancomycin guidelines at your institution
2. Identify potential barriers for implementing vancomycin AUC dosing and monitoring
3. Describe the specific educational and mechanistic methodologies for successfully implementing the vancomycin AUC dosing and monitoring
5:00 pm - 6:00 pmExhibitor's Reception
Saturday, May 22, 2021
6:30 am - 5:00 pmHospitality Desk Open
7:00 am – 8:00 amContinental Breakfast
8:00 am – 9:30 amEmerging and Difficult to Treat Infections (AASP)
ACPE Program: TBA (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Candida auris; Jeffrey Rybak, PharmD, PhD
Learning Objectives:
1. Describe the pharmacological and clinical consequences of antifungal resistance in Candida species
2. Identify epidemiological features associated with Candida auris
3. Recommend and justify two or more infection control and treatment strategies suggested for suspected or known Candida auris
Topic 2: Non-tuberculosis Mycobacteria; Wendy Bullington, PharmD
Learning Objectives:
1. Describe the epidemiology of nontuberculous mycobacterial lung disease (NTM-LD)
2. Outline major recommendations in diagnosis and monitoring of NTM-LD
3. Given a clinical scenario, describe how to implement evidence-based treatment recommendations for NTM-LD
9:30 am – 10:00 amBreak
10:00 am – 11:30 amHot Topics: What did you miss at the other ID Meetings?
ACPE Program: TBA (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: What did you miss at the other ID Meetings (Part 1) Ryan Shields, PharmD, MS
Learning Objectives:
1. Describe an important study presented at a recent ID meeting and explain how you may apply its findings to your practice
2. Discuss the major controversies highlighted at these meetings
3. List the winners and losers for therapeutic advances from this year in ID pharmacotherapy
Topic 2: What did you miss at the other ID Meetings? (Part 2), Erin McCreary, PharmD
Learning Objectives:
1. Summarize the ID Hot topics from the major ID meetings
2. Discuss the major controversies highlighted at these meetings
3. List the winners and losers for therapeutic advances from this year in ID pharmacotherapy
11:30 am - 12:30 pmMeet the Professors
ACPE Program: 0485-0000-20-018-L01-P (1.0 Contact Hour)
Activity Type: Knowledge
Learning Objectives:
1. Summarize the new principles related to antimicrobial stewardship presented at this meeting
2. Hypothesize and /or explain how to implement these strategies for effective stewardship interventions at their own institution
3. Provide examples of how new information and concepts presented at this meeting will affect patient care in your practice setting
12:30 pmMeeting Adjourns